Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery

G Shaw, R Schaefer, HMA Schmidt, A Madden… - Harm reduction …, 2023 - Springer
Abstract Background The World Health Organization (WHO) recommends oral pre-exposure
prophylaxis (PrEP) for all people at substantial risk of HIV as part of combination prevention …

Implementation facilitators and barriers for primary care providers prescribing daily oral PrEP to adolescents in the United States

C Owens, SJ Gray, K Carter, M Hoffman… - AIDS patient care and …, 2023 - liebertpub.com
Primary care providers (PCPs) are critical in prescribing human immunodeficiency virus
(HIV) pre-exposure prophylaxis (PrEP) to adolescents at risk of HIV. More research is …

Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17–24 years old

SA John, JP Zapata, M Dang, B Pleuhs, A O'Neil… - Scientific reports, 2023 - nature.com
Intramuscular cabotegravir for long-acting injectable HIV pre-exposure prophylaxis (ie, LAI-
PrEP) was approved by the US FDA in 2021. We sought to explore LAI-PrEP decision …

Assumptions about patients seeking PrEP: Exploring the effects of patient and sexual partner race and gender identity and the moderating role of implicit racism

SR Bunting, BA Feinstein, SK Calabrese, A Hazra… - PLoS …, 2022 - journals.plos.org
Introduction Daily pre-exposure prophylaxis (PrEP) for HIV-prevention is an essential
component of national plans to end the HIV epidemic. Despite its well-documented safety …

Long-acting injectable human immunodeficiency virus pre-exposure prophylaxis preferred over other modalities among people who inject drugs: Findings from a …

AR Bazzi, CJ Valasek, SA Streuli, CF Vera… - AIDS patient care and …, 2022 - liebertpub.com
People who inject drugs (PWID) have extraordinarily low uptake of human
immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) despite high levels of need …

Assessing Structural Racism and Discrimination Along the Pre-exposure Prophylaxis Continuum: A Systematic Review

S Seyedroudbari, F Ghadimi, G Grady, O Uzosike… - AIDS and behavior, 2024 - Springer
Structural racism and discrimination (SRD) is deeply embedded across US healthcare
institutions, but its impact on health outcomes is challenging to assess. The purpose of this …

Providers' attitudes and experiences with pre-exposure prophylaxis implementation in a population-based study in Kenya and Uganda

CS Camlin, M Getahun, CA Koss, L Owino… - AIDS Patient Care …, 2022 - liebertpub.com
Pre-exposure prophylaxis (PrEP) implementation is underway across sub-Saharan Africa.
However, little is known about health care providers' experiences with PrEP provision in …

Racial and ethnic disparities in HIV testing in people who use drugs admitted to a tertiary care hospital

S Hamdan, E Smyth, ME Murphy… - AIDS Patient Care …, 2022 - liebertpub.com
Ending the HIV epidemic requires increased testing, diagnosis, and linkage to care. In the
past 10 years, rates of HIV have increased among people with substance use disorder …

The long-acting cabotegravir tail as an implementation challenge: planning for safe discontinuation

K Meyers, N Nguyen, JE Zucker, BA Kutner… - AIDS and Behavior, 2023 - Springer
The long-acting feature of cabotegravir, an integrase-inhibitor highly effective in preventing
acquisition of HIV in adolescents and adults, is both its greatest strength and a challenge to …

HIV risk perception, pre-exposure prophylaxis (PrEP) awareness, and PrEP initiation intention among women who use drugs

CK Darlington, RK Lipsky, AM Teitelman… - Journal of Substance …, 2023 - Elsevier
Introduction Women who use drugs (WWUD) are prime candidates for pre-exposure
prophylaxis (PrEP) due to their elevated risk of acquiring HIV through biological, behavioral …